Co-administration of anti-resorptives with i.v. iron infusion is one such risk factor—the inhibition of bone resorption and reduced calcium efflux from bone compounds the iron-infused mediated increase in FGF23 and subsequent blunted parathyroid hormone response, thus resulting in hypocalcemia.45 Here, FGF23 is linked to Hypocalcemia.